We were fortunate to have been successful in recapitalising the company in late December 2019, as a result, we are fully funded to execute our CY2020 objectives, given our strong cash position ($2.9 million at 31 Dec 2019), strategic investment in Davenport Resources ($1.4 million) and a modest monthly cash burn rate. In summary, despite the current market uncertainties and broader challenges associated with a likely COVID-19 related global economic slowdown, we remain focused on the effective execution of our business plan and optimistic about the future of Parkway Minerals and the commercialisation of the aMES™technology.
Great!!
- Forums
- ASX - By Stock
- PWN
- Ann: Corporate Update
Ann: Corporate Update, page-2
-
- There are more pages in this discussion • 23 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PWN (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.1¢ |
Change
-0.001(8.33%) |
Mkt cap ! $30.43M |
Open | High | Low | Value | Volume |
1.2¢ | 1.2¢ | 1.1¢ | $16.90K | 1.528M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 3945073 | 1.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.2¢ | 8760483 | 13 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 3945073 | 0.010 |
15 | 6286982 | 0.009 |
16 | 4936001 | 0.008 |
12 | 7376405 | 0.007 |
5 | 1280009 | 0.006 |
Price($) | Vol. | No. |
---|---|---|
0.012 | 8760483 | 13 |
0.013 | 3042857 | 4 |
0.014 | 307441 | 3 |
0.015 | 1460892 | 4 |
0.016 | 2000864 | 3 |
Last trade - 14.34pm 24/09/2024 (20 minute delay) ? |
Featured News
PWN (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online